Potential Value of Identifying Type 2 Diabetes Subgroups for Guiding Intensive Treatment: A Comparison of Novel Data-Driven Clustering With Risk-Driven Subgroups.
Li X. et al, (2023), Diabetes Care
Estimating the Economic Value of Automated Virtual Reality Cognitive Therapy for Treating Agoraphobic Avoidance in Patients With Psychosis: Findings From the gameChange Randomized Controlled Clinical Trial.
Altunkaya J. et al, (2022), Journal of medical Internet research, 24
Rehabilitation versus surgical reconstruction for non-acute anterior cruciate ligament injury (ACL SNNAP): a pragmatic randomised controlled trial.
Beard DJ. et al, (2022), Lancet, 400, 605 - 615
The WISDOM self-management intervention: a cost-effectiveness analysis to support the transformation of type 2 diabetes care in England.
Singh S. et al, (2022), Diabet Med
Health utilities in Chinese patients with coronary heart disease and impaired glucose tolerance (ACE): A longitudinal analysis of a randomized, double-blind, placebo-controlled trial.
Leal J. et al, (2022), Journal of diabetes, 14, 455 - 464
Hospital costs associated with adverse events in people with diabetes in the UK.
Keng MJ. et al, (2022), Diabetes Obes Metab
The Potential Value of Clustering-Based Type 2 Diabetes Subgroups for Guiding Intensive Treatment: A Maximum Cost-Based Comparison with Threshold-Based Classifications
Li X. et al, (2022), DIABETES, 71
ACL Surgery Necessity in Non-Acute Patients (ACL SNNAP): a statistical analysis plan for a randomised controlled trial.
Stokes JR. et al, (2022), Trials, 23
The transferability and validity of a population-level simulation model for the economic evaluation of interventions in diabetes: the MICADO model.
Emamipour S. et al, (2022), Acta Diabetol
Efficacy of Liposomal Bupivacaine and Bupivacaine Hydrochloride vs Bupivacaine Hydrochloride Alone as a Periarticular Anesthetic for Patients Undergoing Knee Replacement: A Randomized Clinical Trial.
Hamilton TW. et al, (2022), JAMA Surg
Automated virtual reality therapy to treat agoraphobic avoidance and distress in patients with psychosis (gameChange): a multicentre, parallel-group, single-blind, randomised, controlled trial in England with mediation and moderation analyses.
Freeman D. et al, (2022), Lancet Psychiatry
Health-related quality of life for normal glycaemia, prediabetes and type 2 diabetes mellitus: Cross-sectional analysis of the ADDITION-PRO study.
Leal J. et al, (2022), Diabet Med
Costs of Joint Replacement in Osteoarthritis: A Study Using the National Joint Registry and Clinical Practice Research Datalink Data Sets.
Leal J. et al, (2022), Arthritis Care Res (Hoboken), 74, 392 - 402
Decrements in health-related quality of life associated with adverse events in people with diabetes.
Keng MJ. et al, (2022), Diabetes Obes Metab, 24, 530 - 538
Cost-effectiveness of home-based stroke rehabilitation across Europe: A modelling study.
Candio P. et al, (2022), Health Policy
Clinical and Cost-Effectiveness of Liposomal Bupivacaine and Bupivacaine Hydrochloride vs. Bupivacaine Hydrochloride alone as Peri-Articular Anaesthetic for Replacement of the Knee
HAMILTON T. et al, (2022), JAMA Surgery
Impact of adverse events on hospital costs and health-related quality of life in people with diabetes
Keng MJ. et al, (2022), DIABETES RESEARCH AND CLINICAL PRACTICE, 186
Exploring Structural Uncertainty and Impact of Health State Utility Values on Lifetime Outcomes in Diabetes Economic Simulation Models: Findings from the Ninth Mount Hood Diabetes Quality-of-Life Challenge.
Tew M. et al, (2021), Med Decis Making
Lifetime cost-effectiveness simulation of once-weekly exenatide in type 2 diabetes: a cost-utility analysis based on the EXSCEL trial.
Becker F. et al, (2021), Diabetes Res Clin Pract
Performance of the UKPDS Outcomes Model 2 in a contemporary UK type 2 diabetes trial cohort
Keng MJ. et al, (2021), Value in Health